These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35719861)

  • 1. Post-COVID-19 Cholestasis: A Case Series and Review of Literature.
    Kulkarni AV; Khelgi A; Sekaran A; Reddy R; Sharma M; Tirumalle S; Gora BA; Somireddy A; Reddy J; Menon B; Reddy DN; Rao NP
    J Clin Exp Hepatol; 2022; 12(6):1580-1590. PubMed ID: 35719861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
    Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
    Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
    [No Abstract]   [Full Text] [Related]  

  • 4. First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection.
    Rela M; Rajakannu M; Veerankutty FH; Vij M; Rammohan A
    Am J Transplant; 2022 Dec; 22(12):3143-3145. PubMed ID: 35929565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
    Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
    J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of compound Yindan decoction on alpha-naphthylisothiocyanate-Induced acute intrahepatic cholestasis in rats.
    Sun F; Li X; Xu C; Li P; Wu J; Sui J
    J Tradit Chin Med; 2019 Jun; 39(3):315-323. PubMed ID: 32186003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is post COVID-19 cholangiopathy an appropriate indication for liver transplantation?
    Kiyak M; Ayhan R; Yavuz M; Demirtas C; Çakmak S; Altunöz E; İpek S
    Rev Esp Enferm Dig; 2024 Jun; 116(6):336-337. PubMed ID: 37314132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative changes of liver enzymes can distinguish between biliary stricture and graft rejection after living donor liver transplantation: A longitudinal study.
    Woo YS; Lee KH; Lee KT; Lee JK; Kim JM; Kwon CHD; Joh JW; Kang D; Cho J
    Medicine (Baltimore); 2017 Oct; 96(40):e6892. PubMed ID: 28984750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
    Spagnuolo MI; Iorio R; Vegnente A; Guarino A
    Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis.
    Scarsi E; Massucco S; Ferraro PM; Cella A; Grisanti SG; Assini A; Beronio A; Della Cava F; Gemelli C; Bandini F; Serrati C; Del Sette M; Schenone A; Benedetti L; Prada V; Grandis M
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Nonalcoholic Fatty Liver Disease (NAFLD) on COVID-19: A Single-Center Study of 3983 Patients With Review of Literature.
    Nath P; Kumar R; Mallick B; Das S; Anand A; Panigrahi SC; Duseja A; Acharya SK; Chawla YK; Praharaj DL
    Cureus; 2022 Jul; 14(7):e26683. PubMed ID: 35949776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model.
    Ainosah RH; Hagras MM; Alharthi SE; Saadah OI
    J Taibah Univ Med Sci; 2020 Aug; 15(4):312-320. PubMed ID: 32982635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.
    Cao Z; Zhang C; Zhao S; Sheng Z; Xiang X; Li R; Qian Z; Wang Y; Chen B; Li Z; Liu Y; An B; Zhou H; Cai W; Wang H; Gui H; Xin H; Xie Q
    Infect Dis Poverty; 2022 May; 11(1):56. PubMed ID: 35578350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
    Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
    JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, severity, duration and resolution of cholestasis after acute liver failure.
    Warming S; Michel C; Serpa Neto A; Kishore K; Marhoon N; Holmes N; Bellomo R; Testro A; Sinclair M; Gow P; Warrillow S
    BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35473828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.